All In Biotech

Free tool

FAERS Monitor: Serostim

The FDA Adverse Event Reporting System collects reports from patients, clinicians and manufacturers. Counts are unverified reports, not rates: they rise with how widely a drug is used, how long it has been sold and media attention, a report can name several drugs, and a report does not show the drug caused the event.

Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations

Reports naming BLA 020604 or its brand name (Serostim, Somatropin). Reports on generic versions are filed under their own applications.

Reports

6,707

Serious

4,702

70% of reports

Hospitalization

1,615

Death reported

482

Any cause; not necessarily from the drug

Most reported reactions

MedDRA preferred terms.

  • off label use446
  • device leakage334
  • headache252
  • injection site pain224
  • drug dose omission by device219
  • death211
  • fatigue191
  • drug ineffective155
  • device mechanical issue150
  • arthralgia142
  • device issue137
  • product dose omission issue135
  • pyrexia133
  • nausea125
  • sleep apnoea syndrome123

Reports by year received

View as table
YearReports
200448
200525
200637
2007122
200859
2009224
2010174
2011214
2012225
2013103
2014186
2015272
2016385
2017300
2018310
2019485
2020415
2021314
2022485
2023795
2024715
2025479
2026335

Disproportionality screen

Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 21,047,452 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.

ReactionReportsPRR95% CI lowerChi-squared
device mechanical issueSignal15034.729.64,822
device leakageSignal33424.321.97,409
sleep apnoea syndromeSignal12320.317.12,230
drug dose omission by deviceSignal2198.87.71,506
device issueSignal1374.84.1409
injection site painSignal2242.32.0164
off label use4461.61.5103
product dose omission issue1351.41.218
headache2521.31.114
pyrexia1331.21.05
arthralgia1421.10.91
fatigue1910.80.713
death2110.80.715
nausea1250.50.466
drug ineffective1550.40.3178

A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.